166 filings
8-K
TTOO
T2 Biosystems Inc
22 May 24
Other Events
4:49pm
8-K
TTOO
T2 Biosystems Inc
20 May 24
Entry into a Material Definitive Agreement
7:00am
8-K
TTOO
T2 Biosystems Inc
14 May 24
Amendments to Articles of Incorporation or Bylaws
4:43pm
8-K
TTOO
T2 Biosystems Inc
7 May 24
Other Events
4:48pm
8-K
TTOO
T2 Biosystems Inc
6 May 24
T2 Biosystems Announces First Quarter 2024 Financial Results
5:24pm
8-K
qp0045mev11vu d8
18 Apr 24
Entry into a Material Definitive Agreement
4:12pm
8-K
9ucni4 2q709l
12 Apr 24
Submission of Matters to a Vote of Security Holders
4:47pm
8-K
yt6s8 m8bx
28 Mar 24
Regulation FD Disclosure
4:31pm
8-K
neouuodygjbigmkmr70k
20 Mar 24
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
9:17am
8-K
2t1j2c0t
18 Mar 24
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
9:06am
8-K
onz5g0x 3ma
12 Mar 24
Other Events
9:00am
8-K
8u2muu4h09d4
16 Feb 24
Results of Operations and Financial Condition
5:00pm
8-K
mruwzjgrp1kl2bbawodb
15 Feb 24
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
4:47pm
8-K
f5lw0v015rk9e22e
5 Jan 24
Departure of Directors or Certain Officers
4:00pm
8-K/A
ry07gxq ru30mv3
24 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
zz6wd72osq8kn ucatbg
1 Nov 23
Other Events
9:08am
8-K
tw1n87
25 Oct 23
T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
9:02am
8-K
0ecbt73 vu9edc
23 Oct 23
Entry into a Material Definitive Agreement
9:00am
8-K
qyjuk2r0z0z7f9 1f
17 Oct 23
Results of Operations and Financial Condition
4:31pm
8-K
7iaxm4y92 u9c
12 Oct 23
T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
4:32pm